RC Outsourcing LLC recalled 2,669 syringes of Bevacizumab on September 22, 2025. The recall stems from a lack of assurance of sterility, raising significant health risks. Healthcare providers and consumers should stop using the product immediately.
Lack of assurance of sterility.
Consumers and healthcare providers should stop using this product immediately. Contact RC Outsourcing, LLC or your healthcare provider for guidance. Notification method: Letter
The recalled product is Bevacizumab 1.75 mg/0.07 mL in 0.25 mL syringes. The syringes were distributed nationwide in the U.S. and are for hospital or office use only.
The recall is due to a lack of assurance of sterility, which poses a high risk of infection to patients. This is classified as a Class II recall by the FDA.
No specific injuries or incidents have been reported related to this recall. However, the potential for serious health complications exists due to the sterility issue.
Stop using the recalled product immediately. Contact RC Outsourcing LLC or your healthcare provider for guidance on the next steps.
For more information, contact RC Outsourcing LLC at their official website or through the provided FDA link.
Abiomed issued a recall for 10,153 Automated Impella Controllers on October 1, 2025. The devices face potential cybersecurity vulnerabilities related to their operating system. Healthcare providers and patients should stop using these devices immediately.
Acuity Specialty Products recalled its Wyandotte Sanifect E3 hand sanitizer on September 29, 2025. The recall affects multiple package configurations due to potential methanol contamination. Consumers should stop using the product immediately and contact the company for guidance.
AFCO recalled hand sanitizer on September 29, 2025, due to a risk of methanol contamination. The company failed to conduct required testing on incoming alcohol components. Consumers should stop using the product immediately.